VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2022 | The clinical use of MRD in CLL and challenges in this space

Alexey V. Danilov, MD, PhD, City of Hope, Duarte, CA, shares some insights into the clinical use of measurable residual disease (MRD) in chronic lymphocytic leukemia (CLL). Prof. Danilov first highlights methods used in MRD testing, and then goes on to explain the challenges with implementing MRD outside of a clinical trial setting, and the need for more research in this space. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter